New Eyes: Expanding the EVAL-PLH Polyhandicap Cohort
Official title: Third Wave of the EVAL-PLH (POLYhandicap) Cohort: New Eyes
Run by Assistance Publique Hopitaux De Marseille · NCT06811441 · Data updated 2026-11-12
This observational cohort study tests whether widening participation in the EVAL-PLH Polyhandicap cohort can make findings more representative for people with profound intellectual and multiple disabilities.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years and up |
| Sex | All |
| Enrollment | 1102 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 6 sites (Hendaye and 5 other locations) |
| Status | Recruiting |
| Started | October 13, 2025 |
| Main results expected | September 1, 2028 |
| Study ends | September 1, 2028 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT06811441 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people with PIMD/Polyhandicap who are treated within participating centers, their family caregivers aged 18+ who understand French, and institutional caregivers of at least one patient.
✕Probably not a fit
Patients or caregivers who do not participate or do not consent may not experience any study-related benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project aims to broaden enrollment in the EVAL-PLH cohort to reduce geographic and private-structure biases. It follows people with PIMD/Polyhandicap over time to describe health changes, care practices, and family/caregiver experiences. The study design emphasizes longitudinal observation rather than interventional treatments, to identify patterns and determinants in real-world care. Data from participants and their caregivers inform decision-makers and healthcare providers about targeted actions to improve outcomes. Inclusion includes patients aged 3 years and older with PIMD/Polyhandicap and their family or institutional caregivers who understand French and consent where required.
Why it matters
Potential benefit: If successful, the study could provide more representative insights to guide care planning and policy for people with PIMD/Polyhandicap.
How similar studies have gone: Previous EVAL-PLH observations have provided valuable longitudinal insights, but broader participation could strengthen representativeness.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with PIMD/Polyhandicap * Patient for whom the legal representative has received the information note of the EVAL-PLH cohort and has not expressed opposition to the collection of patient data; * Patient aged at least 3 years; * Patient affiliated to a health insurance scheme; * Patient treated within the department of the participating center; * Patient for whom the legal representative understands the French language; * Patient with a PIMD/Polyhandicap Family caregivers of patient * Subject identified by the care structure as the reference family caregiver; * Subject aged at least 18 years; * Subject who understands the French language and is able to complete self-questionnaires; * Subject who has received the information notice and has not expressed opposition to participating in this project Institutinal caregivers of patient * Subject identified by the care structure as the reference institutional caregiver of at least one patient included in this project; * Subject aged at least 18 years; * Subject who understands the French language and is able to complete self-questionnaires; * Subject who has received the information notice and has not expressed opposition to participating in this project. Exclusion Criteria: * Patient with PIMD/Polyhandicap * Patient not meeting all inclusion criteria; * Patient in exclusion period of another research protocol at the time of inclusion. Family and Institutional caregivers of patient • Subject not meeting all inclusion criteria
Where it's running
-
Hôpital Marin de Hendaye
Hendaye, France Recruiting -
Hôpital San Salvadour
Hyères, France Recruiting -
Fondation John Bost
La Force, France Recruiting -
Cesap
Paris, France Recruiting -
Hôpital La Roche Guyon
Paris, France Recruiting -
Assistance Publique Des Hopitaux de Marseille
Marseille, France Not yet recruiting
Study contacts
- Principal investigator: karine Baumstarck — Assistance Publique des Hôpitaux de Marseille (AP-HM)
- Study coordinator: karine Baumstarck
- Email: karine.baumstarck@univ-amu.fr
- Phone: 04 91 32 44 59
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intensive rehabilitation for children with polyhandicap
This study tests if intensive rehabilitation helps children with multiple disabilities improve their daily skills and overall quality of life better than regular care.
-
Cryopreserved autologous SVF plus micrograft for refractory ano-perineal fistulas in Crohn's disease
This trial tests whether thawed stromal vascular fraction (SVF) injected around fistulas can help Crohn’s patients who haven’t responded to prior therapy.
-
Prevention of Recidivism and Better Care for Women Seeking Asylum Who Endure Sexual Violence
This study tests a coordinated care model to support adult women seeking asylum in France who have experienced sexual violence, with the aim of improving health and quality of life.
-
Transition to adulthood for young adults with severe haemophilia
This study tests how young adults with severe haemophilia who were in TRANSHEMO as teens are faring as they move into adulthood.
-
Biomarkers of Response to SEEG Thermocoagulation
This study tests biomarkers to see if they predict how well SEEG-guided radiofrequency thermocoagulation helps people with drug-resistant focal epilepsy.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.